NNMT and obesity due to melanocortin 4 receptor deficiency: Nicotinamide N-methyltransferase (NNMT), an enzyme highly expressed in white adipose tissue (WAT)10, is a recently discovered drug target that has been preclinically validated11–13 and clinically evaluated14,15 for the management of obesity and T2D.